M&A - Page 1 | TalkMarkets
All Posts > Content under M&A
1 to 16 of 1214 Posts
1 2 3 ... 76
Tencent Dominated $22 Billion Games Deals Market In Last 12 Months
Article By: Tim Merel
Wednesday, April 18, 2018 12:08 PM EDT
In games deal making there’s Tencent, then there’s everyone else. Tencent led or participated in over $4 of every $10 invested in games companies worldwide in the 12 months to Q1 2018.
In this article: TCEHY Also: NAPRF, VIVEF, UBSFY, SE
Week In Review: Ping An Good Doctor Plans $1 Billion Hong Kong IPO In Mid-May
Article By: ChinaBio® Today
Saturday, April 14, 2018 4:33 PM EDT
Ping An Insurance plans to carve out its Ping An Healthcare and Technology (also known as Ping An Good Doctor APP) and IPO in Hong Kong for $1 billion at a valuation of $5 billion. The company plans to go public in the middle of May.
In this article: BGNE
U.S. Mergers And Antitrust In 2017
Article By: Timothy Taylor
Wednesday, April 11, 2018 7:00 PM EDT
In 2017, there were 255 mergers and acquisitions of more than $1 billion.
Alexion To Acquire Sweden's Wilson Therapeutics For $855M In Cash
Article By: The Fly
Wednesday, April 11, 2018 8:05 AM EDT
Alexion Pharmaceuticals and Wilson Therapeutics AB announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer.
In this article: ALXN
Biotechs Bounce Off Bottom On Novartis Deal But Fade Later In The Day
Article By: Rod Raynovich
Monday, April 9, 2018 7:49 PM EDT
Normally this kind of M&A news would be an opportunity to load up on biotechs but technicals are still weak and crosscurrents from economic and macro news create a risk-off sentiment.
Position Close Update: Oclaro (OCLR)
Article By: David Trainer
Monday, April 9, 2018 12:34 PM EDT
We stated in our long thesis that an Oclaro acquisition by Finisar or Lumentum (LITE) could be an immediate upside catalyst. Sure enough, LITE made an acquisition offer on March 12 at a 27% premium to OCLR’s stock price at the time.
In this article: OCLR, FNSR, LITE
After Former Citron Short Target AveXis Gets Bought, Analyst Asks 'who's Next'
Article By: The Fly
Monday, April 9, 2018 11:25 AM EDT
AveXis shares are surging after the gene therapy researcher announced an agreement to be acquired by Novartis for $218 per share, or $8.7billion in cash. This comes two years after Citron Research made a short call of a AveXis $5 price target.
In this article: NVS, AVXS Also: BMRN, VYGR, BLUE, ONCE, RGNX
EC M&A Cash To Splash Supports Stocks
Article By: Kurt Kallaus
Sunday, April 8, 2018 6:00 AM EDT
Adding to the positive backdrop in this economic expansion is the massive sideline liquidity in search of corporate assets as well as shares of stock.
In this article: HUM, T, WMT, AMZN, AVGO
Week In Review: Concord Medical Raises $240 Million For China Radiology Services
Article By: ChinaBio® Today
Saturday, April 7, 2018 4:30 PM EDT
Concord Medical Services announced that CICC Capital led an investment of between $238 million and $286 million in Concord’s subsidiary Beijing Meizhong Jiahe Hospital Management. The investors will hold 37.5% to 41.9% of Meizhong Jiahe's equity.
In this article: CCM, LLY
Do Mega Deals Actually Benefit Buyer Shareholders?
Article By: ValueWalk
Friday, April 6, 2018 8:00 AM EDT
Condensing the analysis shows that in the last 20 years, these buyers have largely underperformed the S&P 500 over comparable periods post-closing.
In this article: CVS, DIS, AMZN
Helios And Matheson Rises After Announcing MovieFone Acquisition
Article By: The Fly
Thursday, April 5, 2018 5:07 PM EDT
Shares of Helios and Matheson Analytics are rising after the company announced the acquisition of MovieFone from Verizon's Oath in order to build out its movie theater subscription service MoviePass.
In this article: HMNYD
Hospitals Fear Walmart-Humana Deal
Article By: Mish Shedlock
Sunday, April 1, 2018 3:29 PM EDT
A possible Walmart-Humana deal is scaring hospitals as Walmart is a very sophisticated buyer of health benefits. This will increase pressure on hospital-provided services.
In this article: HUM, WMT
Takeda Confirms Takeover Offer For Shire Under Consideration
Article By: The Fly
Wednesday, March 28, 2018 9:07 AM EDT
Takeda Pharmaceutical overnight confirmed that it is considering making an approach to Shire regarding a possible offer for the company.
In this article: SHPG, TKPYY
Salesforce Under Pressure After Paying Steep Price For MuleSoft
Article By: The Fly
Wednesday, March 21, 2018 12:16 PM EDT
Shares of Salesforce are sliding after the company announced that it is acquiring MuleSoft for $6.5B.
In this article: CRM, MULE
Salesforce Buys MuleSoft For $6.5 Billion
Article By: Sramana Mitra
Wednesday, March 21, 2018 10:11 AM EDT
The global Applications Programming Interface (API) management market is estimated to grow from $609.32 million in 2016 to $ 3.44 billion by 2022. MuleSoft is a leading player in the market.
In this article: MULE Also: CRM
A Glimpse Of Precious Metal Mining’s Future: Hecla Buys Klondex For 59% Premium
Article By: John Rubino
Monday, March 19, 2018 6:28 PM EDT
Big gold and silver miners have a problem: They’re evaporating. Each year they take more metal out of the ground than they discover, which brings them ever-closer to the end of the road.
In this article: GLD, SLV, HL, KLDX
1 to 16 of 1214 Posts
1 2 3 ... 76